{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:50:27Z","timestamp":1786405827996,"version":"build-2736575974"},"publisher-location":"Chichester, UK","reference-count":96,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007325.pub2","type":"reference-entry","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T15:29:36Z","timestamp":1285687776000},"source":"Crossref","is-referenced-by-count":10,"title":["Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion"],"prefix":"10.1002","author":[{"given":"Tasanee","family":"Braithwaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshan A","family":"Nanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archophthalmol.2009.14","article-title":"Pegaptanib sodium for macular edema secondary to central retinal vein occlusion","volume":"127","author":"Wroblewski","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00417-008-0917-1","article-title":"Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide)","volume":"247","author":"Byeon","year":"2009","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD007325.pub2-BIB4|cit4","unstructured":"A randomized study comparing ranibizumab to sham in patients with macular edema secondary to CRVO Ongoing study"},{"key":"10.1002\/14651858.CD007325.pub2-BIB5|cit5","unstructured":"Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion (BRAVO) Ongoing study"},{"key":"10.1002\/14651858.CD007325.pub2-BIB6|cit6","unstructured":"Single site, masked, randomized, controlled study to assess efficacy of Osurdex as adjunct to Avastin compared with Avastin alone in the treatment of patients with macular edema secondary to central or branch retinal vein occlusion Ongoing study"},{"key":"10.1002\/14651858.CD007325.pub2-BIB7|cit7","unstructured":"Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (Regeneron 2010) Ongoing study"},{"key":"10.1002\/14651858.CD007325.pub2-BIB8|cit8","unstructured":"Bevacizumab for Central Retinal Vein Occlusion Study (St. Eriks Eye Hospital 2009) Ongoing study"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-2007-963035","article-title":"Subjective sensations after intravitreal injection of Bevacizumab","volume":"224","author":"Ach","year":"2007","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate","volume":"114","author":"Adamis","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"23","key":"10.1002\/14651858.CD007325.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/IAE.0b013e3181744153","article-title":"Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"28","author":"Arevalo","year":"2008","journal-title":"Retina"},{"issue":"12","key":"10.1002\/14651858.CD007325.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab\u00a0(Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal disease","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007325.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","article-title":"Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion","volume":"120","author":"Boyd","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/jop.2007.0012","article-title":"Short-term results of intravitreal Bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema","volume":"23","author":"Byeon","year":"2007","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mt.2008.10","article-title":"Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator","volume":"16","author":"Campochiaro","year":"2008","journal-title":"Molecular Therapy"},{"issue":"11","key":"10.1002\/14651858.CD007325.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ophtha.2009.04.038","article-title":"Monitoring ocular drug therapy by analysis of aqueous samples","volume":"116","author":"Campochiaro","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2005.02.053","article-title":"Characterization of macular edema from various etiologies by optical coherence tomography","volume":"140","author":"Catier","year":"2005","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":"Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study","volume":"27","author":"Costa","year":"2007","journal-title":"Retina"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB23|cit23","first-page":"1275","article-title":"Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group","volume":"115","year":"1997","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajo.2008.10.024","article-title":"Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion","volume":"147","author":"DeCroos","year":"2009","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown","volume":"80","author":"Edelman","year":"2005","journal-title":"Experimental Eye Research"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/01.iae.0000236461.31264.c6","article-title":"Venous occlusive disease: the latest in current management","volume":"26","author":"Everett","year":"2006","journal-title":"Retina"},{"key":"10.1002\/14651858.CD007325.pub2-BIB27|cit27","unstructured":"Eyetech Inc Macugen - Pegatanib sodium injection www.macugen.com\/macugenUSPI.pdf 2008"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1167\/iovs.08-2510","article-title":"Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab","volume":"50","author":"Funk","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD007325.pub2-BIB29|cit29","unstructured":"Genentech Inc Lucentis: Full prescribing information www.gene.com\/gene\/products\/information\/pdf\/lucentis-prescribing.pdf 2008"},{"key":"10.1002\/14651858.CD007325.pub2-BIB30|cit30","unstructured":"Genentech Inc Avastin: Full prescribing information www.gene.com\/gene\/products\/information\/pdf\/avastin-prescribing.pdf 2009"},{"key":"10.1002\/14651858.CD007325.pub2-BIB31|cit31","unstructured":"Genentech\/Roche Lucentis - Ranibizumab injection: Product Information Home www.gene.com\/gene\/products\/information\/tgr\/lucentis\/ 2009"},{"key":"10.1002\/14651858.CD007325.pub2-BIB32|cit32","unstructured":"Genetech\/Roche Avastin: Product Information Home www.gene.com\/gene\/products\/information\/oncology\/avastin\/ 2009"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB33|cit33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007324.pub2","article-title":"Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion","author":"Gewaily","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB34|cit34","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"27","key":"10.1002\/14651858.CD007325.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007325.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","article-title":"Novel method for analyzing snellen visual acuity measurements","volume":"30","author":"Gregori","year":"2010","journal-title":"Retina"},{"issue":"3-4","key":"10.1002\/14651858.CD007325.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1002130005227","article-title":"The pathogenesis and clinical presentation of macular edema in inflammatory diseases","volume":"97","author":"Guex-Crosier","year":"1999","journal-title":"Documenta Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00417-006-0501-5","article-title":"Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases","volume":"245","author":"Hasselbach","year":"2007","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion","volume":"90","author":"Hayreh","year":"1983","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00920049","article-title":"Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study","volume":"228","author":"Hayreh","year":"1990","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(14)70001-7","article-title":"Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics","volume":"117","author":"Hayreh","year":"1994","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion","volume":"131","author":"Hayreh","year":"2001","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000068980","article-title":"Management of central retinal vein occlusion","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about acute retinal vascular occlusive disorders","volume":"24","author":"Hayreh","year":"2005","journal-title":"Progress in Retinal and Eye Research"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archopht.1995.01100080071031","article-title":"Quantitative assessment of macular edema with optical coherence tomography","volume":"113","author":"Hee","year":"1995","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD007325.pub2-BIB47|cit47","doi-asserted-by":"crossref","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184.ch8"},{"issue":"12","key":"10.1002\/14651858.CD007325.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00417-009-1151-1","article-title":"Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion","volume":"247","author":"Hoeh","year":"2009","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/107327480701400312","article-title":"Spectrum of activity and mechanism of action of VEGF\/PDGF inhibitors","volume":"14","author":"Homsi","year":"2007","journal-title":"Cancer Control"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/IAE.0b013e318050ca7c","article-title":"Intravitreal bevacizumab (avastin) in central retinal vein occlusion","volume":"27","author":"Hsu","year":"2007","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"10.1002\/14651858.CD007325.pub2-BIB52|cit52","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study","volume":"98","author":"Klein","year":"2000","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archopht.126.4.513","article-title":"The 15-year cumulative incidence of retinal vein occlusion: the beaver dam eye study","volume":"126","author":"Klein","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjo.2007.127282","article-title":"Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study","volume":"92","author":"Kriechbaum","year":"2008","journal-title":"British Journal of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007325.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2009.05.001","article-title":"Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year","volume":"116","author":"Kriechbaum","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1634\/theoncologist.12-4-443","article-title":"Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer","volume":"12","author":"Los","year":"2007","journal-title":"Oncologist"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1345\/aph.1H316","article-title":"Bevacizumab for neovascular ocular diseases","volume":"41","author":"Lynch","year":"2007","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/IAE.0b013e31804a7af2","article-title":"Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease","volume":"27","author":"Matsumoto","year":"2007","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ophtha.2009.10.026","article-title":"The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion","volume":"117","author":"McAllister","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ophtha.2010.01.060","article-title":"Natural history of central retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"McIntosh","year":"2010","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10633-007-9110-9","article-title":"Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study","volume":"116","author":"Moschos","year":"2008","journal-title":"Documenta Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajo.2006.06.068","article-title":"Vascular endothelial growth factor is a critical stimulus for diabetic macular edema","volume":"142","author":"Nguyen","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006982-200603000-00008","article-title":"Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases","volume":"26","author":"Opremcak","year":"2006","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","article-title":"Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion","volume":"143","author":"Pai","year":"2007","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/IAE.0b013e3180603071","article-title":"Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion","volume":"27","author":"Park","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/IAE.0b013e3181bced68","article-title":"Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion","volume":"30","author":"Park","year":"2010","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB69|cit69","first-page":"638","article-title":"Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases","volume":"72","author":"Pe'er","year":"1995","journal-title":"Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion","volume":"105","author":"Pe'er","year":"1998","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ophtha.2008.06.021","article-title":"Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions","volume":"115","author":"Pieramici","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2008-1027258","article-title":"Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results","volume":"225","author":"Pournaras","year":"2008","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjo.2008.141085","article-title":"Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial","volume":"93","author":"Prager","year":"2009","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007325.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/IAE.0b013e3180ed458d","article-title":"Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial","volume":"27","author":"Priglinger","year":"2007","journal-title":"Retina"},{"issue":"5-6","key":"10.1002\/14651858.CD007325.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000073587","article-title":"Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach","volume":"32","author":"Prisco","year":"2002","journal-title":"Pathophysiology of Haemostasis & Thrombosis"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9394(14)76979-X","article-title":"The natural course of central retinal vein occlusion","volume":"110","author":"Quinlan","year":"1990","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007325.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/112067210901900625","article-title":"Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion","volume":"19","author":"Raszewska-Steglinska","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1755-3768.2008.01313.x","article-title":"Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion","volume":"87","author":"Rensch","year":"2009","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD007325.pub2-BIB79|cit79","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surgery, Lasers & Imaging"},{"issue":"12","key":"10.1002\/14651858.CD007325.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00417-009-1138-y","article-title":"Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study","volume":"247","author":"Rouvas","year":"2009","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1442-9071.2009.01914.x","article-title":"Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion","volume":"37","author":"Sakamoto","year":"2009","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00347-007-1509-x","article-title":"Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion","volume":"104","author":"Schaal","year":"2007","journal-title":"Ophthalmologe"},{"issue":"9","key":"10.1002\/14651858.CD007325.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5","volume":"127","author":"Ip","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007325.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0161-6420(86)33751-5","article-title":"Relative afferent pupillary defect in central retinal vein occlusion","volume":"93","author":"Servais","year":"1986","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210301300505","article-title":"Central retinal vein occlusion risk profile: a case-control study","volume":"13","author":"Shahsuvaryan","year":"2003","journal-title":"European Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10633-007-9090-9","article-title":"Electrophysiological and structural assessment of the central retinal following intravitreal injection of bevacizumab for treatment of macular edema","volume":"116","author":"Shetty","year":"2008","journal-title":"Documenta Ophthalmologica"},{"issue":"7","key":"10.1002\/14651858.CD007325.pub2-BIB88|cit88","first-page":"1334","article-title":"Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis","volume":"37","author":"Shima","year":"1996","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD007325.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajo.2008.08.016","article-title":"Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion","volume":"147","author":"Spaide","year":"2009","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007325.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1600-0420.2006.00740.x","article-title":"Intravitreal bevacizumab treatment for macular oedema due to central retinal vein occlusion","volume":"84","author":"Spanday","year":"2006","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD007325.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00417-007-0569-6","article-title":"Bevacizumab in retinal vein occlusion-results of a prospective case series","volume":"245","author":"Stahl","year":"2007","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"3-4","key":"10.1002\/14651858.CD007325.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1002136712070","article-title":"Cellular mechanisms of blood-retinal barrier dysfunction in macular edema","volume":"97","author":"Vinores","year":"1999","journal-title":"Documenta Ophthalmologica"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB93|cit93","first-page":"315","article-title":"Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen","volume":"34","author":"Wright","year":"2007","journal-title":"Undersea & Hyperbaric Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007325.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD007325.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/IAE.0b013e3181cea68d","article-title":"Intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: Results of the Pan American Collaborative Retina Study Group at 24 Months","volume":"30","author":"Wu","year":"2010","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD007325.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00417-004-1046-0","article-title":"Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy","volume":"243","author":"Zambarakji","year":"2005","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007325.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007325.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T20:31:29Z","timestamp":1711830689000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007325.pub2"}},"subtitle":[],"editor":[{"given":"Tasanee","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":96,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007325.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007325.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,10,6]]}}}